Molina Healthcare (MOH)
(Delayed Data from NYSE)
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Zacks News
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKJ
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
Universal Health Services (UHS) Q3 Earnings: A Beat in the Cards?
by Zacks Equity Research
United Health's (UHS) third quarter is likely to gain from solid segmental performances and higher number of admissions.
Molina (MOH) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Obamacare Set to Gain From Mid-Term Polls: 4 HMO Picks
by Swarup Gupta
HMOs, which have expanded their market share in the post-Obamacare era, are expected to gain from this trend.
Centene's (CNC) Earnings and Revenues Top Estimates in Q3
by Zacks Equity Research
Execution of growth strategy as well as the company's solid operating metrics leads Centene (CNC) to an earnings beat in Q3.
Molina Healthcare (MOH) Divests Arm to Streamline Business
by Zacks Equity Research
Molina Healthcare (MOH) sells its subsidiary Pathways Health and Community Support, LLC to focus on core business and continue with its plan for margin recovery sustainability.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
New Strong Buy Stocks for October 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
What's in Store for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene's (CNC) third quarter should exhibit strong performances by its Government-backed and Medicaid businesses.
UnitedHealth's (UNH) Q3 Earnings Beat, 2018 Guidance Raised
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results gained from higher revenues from both its segments and increase in membership.
Will Optum Aid UnitedHealth Group's (UNH) Q3 Earnings?
by Zacks Equity Research
Revenue and earnings gains across all the Optum's subsegments should aid UnitedHealth's Q3 earnings.
Will UnitedHealth's (UNH) Revenue Growth Aid Q3 Earnings?
by Zacks Equity Research
Revenue growth at the company's Optum and United Healthcare segments should drive earnings in Q3.
Why the Earnings Surprise Streak Could Continue for Molina (MOH)
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Molina Healthcare Sells MMS Unit to Streamline Business
by Zacks Equity Research
Molina Healthcare (MOH) sells its Medicaid Solutions unit to focus on core operations.
Community Health Divests Unit to Focus on Core Business
by Zacks Equity Research
Community Health (CYH) completes the pending sale of 238-bed AllianceHealth Deaconess hospital to lower debts and concentrate more on core business.
DXC Expands Services Portfolio With Buyout of Argodesign
by Zacks Equity Research
DXC's acquisition of Argodesign not only adds product designing services to its portfolio, but also will aid in accelerating the digital transformation journey of its clients.
Employer Sponsored Health Insurance Premiums Jump: 4 Picks
by Ritujay Ghosh
An increasing number of memberships, with unemployment rate hitting a record low, have been one of the prime factors behind the top-line growth of the health insurance sector.
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKJ
Community Health's (CYH) Ratings Downgraded, Outlook Stable
by Zacks Equity Research
Moody's Investors Service downgrades Community Health's (CYH) ratings. Outlook for the same is stable.
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio (revised)
by Zacks Equity Research
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio
by Zacks Equity Research
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.
6 Reasons to Invest in WellCare Health for Portfolio Boost
by Zacks Equity Research
Banking on strong financial position, inorganic growth and a solid top-line improvement, WellCare Health (WCG) possesses great potential to generate high returns for investors.
Molina (MOH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.